These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 23529904)

  • 1. Agreement between ICU clinicians and electrophysiology cardiologists on the decision to initiate a QTc-interval prolonging medication in critically ill patients with potential risk factors for torsade de pointes: a comparative, case-based evaluation.
    Fongemie JM; Al-Qadheeb NS; Estes NA; Roberts RJ; Temtanakitpaisan Y; Ruthazer R; Devlin JW
    Pharmacotherapy; 2013 Jun; 33(6):589-97. PubMed ID: 23529904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature.
    Lawrence KR; Nasraway SA
    Pharmacotherapy; 1997; 17(3):531-7. PubMed ID: 9165555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of uncorrected versus corrected QT interval for prediction of torsade de pointes associated with intravenous haloperidol.
    Tisdale JE; Kovacs R; Mi D; McCabe GP; Cariera BL; Sharma N; Rosman H
    Pharmacotherapy; 2007 Feb; 27(2):175-82. PubMed ID: 17253907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill.
    Metzger E; Friedman R
    J Clin Psychopharmacol; 1993 Apr; 13(2):128-32. PubMed ID: 8463445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond?
    Meyer-Massetti C; Cheng CM; Sharpe BA; Meier CR; Guglielmo BJ
    J Hosp Med; 2010 Apr; 5(4):E8-16. PubMed ID: 20394022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Torsade de pointes associated with the administration of intravenous haloperidol:a review of the literature and practical guidelines for use.
    Hassaballa HA; Balk RA
    Expert Opin Drug Saf; 2003 Nov; 2(6):543-7. PubMed ID: 14585064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haloperidol-induced torsade de pointes.
    O'Brien JM; Rockwood RP; Suh KI
    Ann Pharmacother; 1999 Oct; 33(10):1046-50. PubMed ID: 10534216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing ICU Subsyndromal Delirium Conversion to Delirium With Low-Dose IV Haloperidol: A Double-Blind, Placebo-Controlled Pilot Study.
    Al-Qadheeb NS; Skrobik Y; Schumaker G; Pacheco MN; Roberts RJ; Ruthazer RR; Devlin JW
    Crit Care Med; 2016 Mar; 44(3):583-91. PubMed ID: 26540397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of Torsades de Pointes.
    Tisdale JE; Rasty S; Padhi ID; Sharma ND; Rosman H
    J Clin Pharmacol; 2001 Dec; 41(12):1310-8. PubMed ID: 11762558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torsade de pointes and low-dose oral haloperidol.
    Jackson T; Ditmanson L; Phibbs B
    Arch Intern Med; 1997 Sep; 157(17):2013-5. PubMed ID: 9308514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Torsades de pointes secondary to intravenous haloperidol after coronary bypass grafting surgery.
    Perrault LP; Denault AY; Carrier M; Cartier R; Bélisle S
    Can J Anaesth; 2000 Mar; 47(3):251-4. PubMed ID: 10730737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Torsade de pointes following intravenous haloperidol administration in a patient with complete heart block.
    Ginwalla M; Biblo LA; Paydak H
    WMJ; 2009 Feb; 108(1):48-50. PubMed ID: 19326637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current perceptions and practices surrounding the recognition and treatment of delirium in the intensive care unit: a survey of 250 critical care pharmacists from eight states.
    Devlin JW; Bhat S; Roberts RJ; Skrobik Y
    Ann Pharmacother; 2011 Oct; 45(10):1217-29. PubMed ID: 21934036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotics and the QTc Interval During Delirium in the Intensive Care Unit: A Secondary Analysis of a Randomized Clinical Trial.
    Stollings JL; Boncyk CS; Birdrow CI; Chen W; Raman R; Gupta DK; Roden DM; Rivera EL; Maiga AW; Rakhit S; Pandharipande PP; Ely EW; Girard TD; Patel MB
    JAMA Netw Open; 2024 Jan; 7(1):e2352034. PubMed ID: 38252439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of haloperidol infusions to control delirium in critically ill adults.
    Seneff MG; Mathews RA
    Ann Pharmacother; 1995; 29(7-8):690-3. PubMed ID: 8520081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of baseline risk factors for QTc interval prolongation in patients prescribed intravenous haloperidol.
    Muzyk AJ; Rayfield A; Revollo JY; Heinz H; Gagliardi JP
    Drug Saf; 2012 Jul; 35(7):547-53. PubMed ID: 22702639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly.
    Vieweg WV; Wood MA; Fernandez A; Beatty-Brooks M; Hasnain M; Pandurangi AK
    Drugs Aging; 2009; 26(12):997-1012. PubMed ID: 19929028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study.
    Devlin JW; Roberts RJ; Fong JJ; Skrobik Y; Riker RR; Hill NS; Robbins T; Garpestad E
    Crit Care Med; 2010 Feb; 38(2):419-27. PubMed ID: 19915454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Torsade de pointes associated with the administration of intravenous haloperidol.
    Hassaballa HA; Balk RA
    Am J Ther; 2003; 10(1):58-60. PubMed ID: 12522522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A computerized physician order entry set designed to improve safety of intravenous haloperidol utilization: a retrospective study in agitated hospitalized patients.
    Muzyk AJ; Rivelli SK; Jiang W; Heinz H; Rayfield A; Gagliardi JP
    Drug Saf; 2012 Sep; 35(9):725-31. PubMed ID: 22876752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.